Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

82.0K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
82.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Pervasive Negative Regulation of Ion Channel Functional Families Across Human Cancers.

American journal of physiology. Cell physiology·2026
Same author

Outcomes on pseudophakic mini-monovision with monofocal intraocular lens on intermediate vision with immediate sequential bilateral cataract surgery.

Eye (London, England)·2026
Same author

Comparison of four attenuation-compensation methods for backscatter coefficient estimation and characterization of focal liver lesions.

Physics in medicine and biology·2026
Same author

Multifrequency MR elastography for grading inflammation in metabolic dysfunction-associated steatotic liver disease: a pilot study.

Radiology advances·2025
Same author

The Canadian Hepatopulmonary Syndrome Program: A Longitudinal Liver Transplant Experience.

Journal of clinical and experimental hepatology·2025
Same author

Intracellular calcium-induced ROS generation promotes squaraine phototoxicity.

Biochimica et biophysica acta. Molecular cell research·2025

Related Experiment Video

Updated: Nov 7, 2025

Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

3.2K

TRP Channels in Brain Tumors.

Giorgia Chinigò1,2, Hélène Castel3,4, Oana Chever3,4

  • 1Laboratory of Cell Physiology, Department of Life Sciences, Univ. Lille, Inserm, U1003 - PHYCEL, University of Lille, Lille, France.

Frontiers in Cell and Developmental Biology
|April 30, 2021
PubMed
Summary

Transient receptor potential (TRP) channels are emerging as key players in glioblastoma (GBM) development and treatment resistance. Targeting TRP channels offers new therapeutic strategies for high-grade gliomas.

Keywords:
TRP channelbrain tumorglioblastomagliomaion channel

More Related Videos

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

18.6K
Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
04:01

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

2.7K

Related Experiment Videos

Last Updated: Nov 7, 2025

Translational Orthotopic Models of Glioblastoma Multiforme
07:37

Translational Orthotopic Models of Glioblastoma Multiforme

Published on: February 17, 2023

3.2K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

18.6K
Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
04:01

Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures

Published on: June 23, 2023

2.7K

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Malignant glioma, particularly glioblastoma (GBM), is a highly aggressive primary brain tumor with poor prognosis.
  • Treatment resistance in GBM is driven by tumor heterogeneity, angiogenesis, and hypoxic microenvironments, leading to recurrence.
  • Transient receptor potential (TRP) channels, involved in cellular responses to stimuli, are increasingly recognized for their role in cancer, including glioma.

Purpose of the Study:

  • To explore the potential of TRP channels as diagnostic and prognostic biomarkers in glioma.
  • To elucidate the mechanisms by which TRP channels influence glioma progression and treatment resistance.
  • To identify novel therapeutic targets within the TRP channel superfamily for high-grade glioma treatment.

Main Methods:

  • Review of current literature on TRP channels in glioma.
  • Analysis of TRP channel involvement in key cancer pathways such as proliferation, cell cycle, apoptosis, DNA repair, and migration/invasion.
  • Discussion of specific TRP channels (TRPC6, TRPM8, TRPV4, TRPV1/V2, TRPM2) and their roles in glioma.

Main Results:

  • Certain TRP channels (TRPC6, TRPM8, TRPV4, TRPV1/V2) are associated with glioma patient overall survival.
  • TRP channels modulate glioma progression through Ca2+ permeability and kinase function, impacting miRNA and signaling cascades.
  • TRPC6 is implicated in GBM growth and invasiveness, TRPV2 in proliferation and stem cell differentiation, and TRPM2 in chemotherapy delivery.

Conclusions:

  • TRP channels represent promising biomarkers for glioma diagnosis and prognosis.
  • Understanding TRP channel mechanisms provides insights into overcoming GBM treatment resistance and recurrence.
  • Targeting TRP channels offers innovative therapeutic strategies for high-grade gliomas.